Lipohypertrophy has been a recognized complication of insulin therapy. Despite improvements in insulin purity and the introduction of recombinant human insulin. its prevalence has remained high particularly in those with a poor glycemic control. Injection of insulin into a site of lipohypertrophy. https://www.spidertattooz.com/Zenith-El-Primero-36-000-VpH-03-2150-400/